Recruiting Now

The Role of Sympathetic Nervous Activation in Remote Ischemic Preconditioning

+ Healthy males

+ Ages between 18-30 years

+ Ages between 60-75 years 

+ Must be non-smokers

+ Must not be using any medications

What's it about?

Remote ischemic preconditioning (RIPC) is a type of therapy which has shown effectiveness in reducing the severity of heart attacks. 

 Our research team will determine whether the protection of RIPC can be replicated with drugs that block this activity. It is hoped that this study will demonstrate the importance of inhibiting “fight or flight” responses with RIPC or medication.

If you are interested in participating in this study, or would like more information, please contact Anu Joyson 9224 0390

Recruiting Now

Sympathoinhibition as a preferred second line treatment of obesity related hypertension

+ Aged between 25 and 65

+ Must have a BMI>30

+ Diagnosed with High Blood Pressure 

​

What's it about?

This research aims to optimize the treatment of hypertension in obesity and will compare the effectiveness of two medication combinations in lowering blood pressure and determine which combination therapy has a more beneficial effect on the symptoms/risk factors associated with obesity.    

​

If you are interested in participating or for more information, please call Alice Rothwell on 9224 0240 or email

Recruiting Now

QUARTET 

+ Diagnosed with High Blood Pressure

+ Must be over 18 years

+ Not on more than one anti-hypertensive medication

​

What's it about?

​The study aims to investigate whether a single pill containing 4 types of blood pressure lowering medications at quarter- standard doses will more effectively lower blood pressure and have fewer side effects compared to a standard dose of a single type of hypertensive medication. ​Participants will have high blood pressure and are either not currently on treatment, or only taking one blood pressure lowering medication.

​

If you are interested in participating in this study, or would like more information, please contact Justine Chan on 9224 0380 or email  

​

​

​

Recruiting Now

Effects of SGLT-2 inhibition on Sympathetic Nervous System Activity in Humans

+ BMI >30

+ Diagnosed with type 2 diabetes or metabolic syndrome

+ Aged between 25-65 years

+ Diagnosed with High Blood Pressure

​

​

If you are interested in participating in this study, or would like more information, please contact Anu Joyson 9224 0390